FIELD: medicine.
SUBSTANCE: invention relates to pharmaceutics and medicine and concerns an oral medicinal form of a phospholipid preparation for prevention and treatment of hepatopathy, lipid storage disease and hepatic function recovery following intoxication, in the form of nanoparticles of diametre 30-50 nm, containing vegetable phospholipids with phosphatidyl choline content 75-98%, glycyrrhizic acid or its pharmaceutically acceptable salt and a carbohydrate with the total content of phospholipids and glycyrrhizic acid or its pharmaceutically acceptable salt 2-80 wt % and mass ratio of phospholipids to glycyrrhizic acid or its pharmaceutically acceptable salt 4:1 or less, as well as method for making thereof by mixture emulsion of vegetable phospholipids in aqueous solution of glycyrrhizic acid or its pharmaceutically acceptable salt with aqueous solution of carbohydrates at pH 6.5-7.5, then followed with homogenisation at pressure 800-1200 bar and sublimation drying.
EFFECT: there is developed oral medicinal form of the phospholipid preparation for prevention and treatment of hepatopathy, lipid storage disease and hepatic function recovery following intoxication.
3 cl, 1 ex, 3 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREPARING INJECTION MEDICINAL FORMULATION OF PHOSPHOLIPID PREPARATION "FOSFOGLIV" FOR TREATMENT AND PROPHYLAXIS OF ACUTE AND CHRONIC HEPATIC DISEASES | 2005 |
|
RU2304430C2 |
PHOSPHOLIPID THERAPEUTIC COMPOSITION WITH NANO-SIZED PARTICLES FOR LIPID STORAGE DISEASE AND COMATOSE STATES AND METHOD FOR PREPARING IT | 2010 |
|
RU2448715C1 |
COMPOSITION EXHIBITING PROPERTY FOR BIOLOGICAL MEMBRANE REPAIRING | 1998 |
|
RU2133122C1 |
PHOSPHOLIPID NANOFORM FOR ORAL APPLICATION (SACHET) AND METHOD FOR PREPARING IT (VERSIONS) | 2010 |
|
RU2463057C2 |
METHOD FOR PREPARING CAPSULATED MEDICINAL FORMULATION OF PHOSPHOLIPID PREPARATION "FOSFOGLIV" FOR TREATMENT AND PROPHYLAXIS OF ACUTE AND CHRONIC HEPATIC DISEASES | 2005 |
|
RU2304431C2 |
MEDICAL PRODUCT AND METHOD OF RHEUMATIC DISEASES TREATMENT | 2006 |
|
RU2330664C2 |
PHARMACEUTICAL COMPOSITION BASED ON DOXORUBICINE AND PHOSPHOLIPID NANOPARTICLES FOR TREATMENT OF ONCOLOGIC DISEASES | 2009 |
|
RU2411935C1 |
PHARMACEUTICAL COMPOSITION OF INDOMETACIN INCLUDED IN PHOSPHOLIPID NANOPARTICLES FOR TREATING RHEUMATIC AND INFLAMMATORY DISEASES | 2009 |
|
RU2417079C1 |
METHOD FOR PREPARING MAGNET-SENSITIVE LIPID COMPOSITE | 2012 |
|
RU2502505C2 |
PHARMACEUTIC COMPOSITION INCLUDING ARBIDOL IN COMPOSITION OF PHOSPHOLIPID NANOPARTICLES | 2009 |
|
RU2411942C2 |
Authors
Dates
2009-11-27—Published
2008-04-14—Filed